Technology

OMNI Conversion Technologies Inc.: Sale and Investment Solicitation Process

Published

1 year ago

December 6, 2024

TORONTO, Dec. 6, 2024 /CNW/ – OMNI Conversion Technologies Inc. (OMNI), a clean energy technology company, announces the commencement of a sale and investment solicitation process (SISP) in respect of the business, assets, and undertakings of OMNI (collectively, the Business). OMNI manufactures the proprietary Omni200 Gasification and Plasma Refining System, a waste-to-value gasification system designed to convert any solid energetic material into clean energy, including hydrogen, renewable natural gas, and sustainable aviation fuel. The SISP will be conducted by Grant Thornton Limited (GTL) in its capacity as proposal trustee (in such capacity, the Proposal Trustee), with the assistance of OMNI.

The SISP will be conducted in the context of the Company’s Notice of Intention to make a Proposal proceedings (NOI) wherein the Ontario Superior Court of Justice (Commercial List) (the Court) issued on November 29, 2024 an order authorizing the Proposal Trustee, in conjunction with the Company, to undertake a SISP for the sale of OMNI’s business.

The SISP is intended to solicit interest in and opportunities for a sale of, or investment in, all or part of the Company’s Business. This may include one or more of a restructuring, recapitalization, or other form of reorganization of the business and affairs of all or part of the Company as a going concern, or a sale of all, substantially all, or a portion of the Company’s Business as a going concern or otherwise.

Interested parties who wish to submit a bid must deliver a non-binding letter of intent to the Proposal Trustee in accordance with the SISP by no later than 5:00 p.m. Eastern Standard Time on January 17, 2025 (the Phase I Bid Deadline). The Proposal Trustee and the Company will assess the letters of intent received on or before the Phase I Bid Deadline and may proceed to a second phase of the process (Phase 2) or alternatively, proceed to negotiate definitive transaction documentation with a bidder or terminate the SISP. Should the SISP proceed to Phase 2, qualified bidders will be notified. Any transaction will be subject to the approval of the Court.

A copy of the SISP, and other relevant documentation relating to the NOI are available on the Proposal Trustee’s website: www.DoaneGrantThornton.ca/OMNI. Any party interested in participating in the SISP can find a copy of the solicitation letter and non-disclosure agreement (NDA) on the Proposal Trustee’s website, and may gain access to due diligence materials and the confidential information memorandum by executing the NDA and emailing it to David.collins@doane.gt.ca, subject line “OMNI NDA – Bidder Name”.

About Grant Thornton Limited

Grant Thornton Limited, Licensed Insolvency Trustees, is one of the largest bankruptcy, insolvency, and restructuring service firms in Canada. The debt professionals at Grant Thornton are passionate about making a difference for their clients, colleagues, and communities. Grant Thornton Limited is a Canadian member of Grant Thornton International Ltd. We have offices conveniently located across Canada, and offer a full range of debt help services for the audit, tax, and advisory firm, Doane Grant Thornton LLP.

About Doane Grant Thornton LLP

Doane Grant Thornton LLP is a leading Canadian accounting and business advisory firm providing accounting, assurance, tax, and advisory services to private and public organizations. We help dynamic organizations unlock their potential for growth by providing meaningful, actionable advice through a broad range of services. Doane Grant Thornton LLP is a Canadian member of Grant Thornton International Ltd, whose member and correspondent firms operate in more than 130 countries worldwide. A listing of Doane Grant Thornton offices and contact information can be found at: www.DoaneGrantThornton.ca.

SOURCE Grant Thornton Limited

Technology

IGCS International Announces Strategic Equity Investment by Lacks Enterprises

Published

7 minutes ago

April 22, 2026

DALLAS, April 22, 2026 /PRNewswire/ — IGCS International, a CVE-certified SDVOSB and leading provider of mission support and MRO supplies to the U.S. Department of Defense and federal agencies, today announced that Lacks Enterprises has acquired an equity stake in the company.

The strategic investment combines IGCS’s expertise in government supply chain, logistics, and MRO solutions with Lacks Enterprises’ advanced manufacturing capabilities, including electroplating, injection molding, composites, and testing for aerospace and defense.

“IGCS has built a strong track record supporting the Department of Defense… Partnering with Lacks Enterprises allows us to integrate cutting-edge manufacturing innovation into our offerings,” said Russ Spears, President of IGCS International.

Media Contact: Russ Spears, 214-733-7278, russ@igcsintl.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/igcs-international-announces-strategic-equity-investment-by-lacks-enterprises-302750824.html

SOURCE IGCS International

Technology

Shoulder Innovations to Report First Quarter 2026 Financial Results on May 13, 2026

Published

7 minutes ago

April 22, 2026

GRAND RAPIDS, Mich., April 22, 2026 /PRNewswire/ — Shoulder Innovations, Inc. (“Shoulder Innovations”) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the first quarter of 2026 after market close on Wednesday, May 13, 2026.

Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on May 13, 2026. Those interested in listening to the conference call may do so by dialing (877) 407-8216 for domestic callers or (412) 902-1015 for international callers and providing access code 13759613. A live and archived webcast of the event will be available in the “Investor Relations” section of the Shoulder Innovations website at https://ir.shoulderinnovations.com/.

About Shoulder Innovations
Shoulder Innovations is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, with a current offering of advanced implant systems for shoulder arthroplasty. These systems are a core element of Shoulder Innovations’ ecosystem, which is designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain. Shoulder Innovations’ ecosystem is also comprised of enabling technologies, efficient instrument systems, specialized support and surgeon-to-surgeon collaboration. Together, these elements seek to address the long-standing clinical and operational challenges in the shoulder surgical care market by delivering predictable outcomes, procedural simplicity, and efficiency across all sites of care.

Contact
Brian Johnston or Sam Bentzinger
Gilmartin Group LLC
ir@shoulderinnovations.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/shoulder-innovations-to-report-first-quarter-2026-financial-results-on-may-13-2026-302750154.html

SOURCE Shoulder Innovations

Technology

Accuray to Report Third Quarter Fiscal 2026 Financial Results on May 6, 2026

Published

7 minutes ago

April 22, 2026

MADISON, Wis., April 22, 2026 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2026, ended March 31, 2026, during a conference call hosted by company management at 1:30 p.m. PT/4:30 p.m. ET on May 6, 2026.

The conference call dial-in numbers are 1-833-316-0563 (USA) or 1-412-317-5747 (international). In addition, a dial-up replay of the conference call will be available approximately one hour after the call’s conclusion for one week. The replay number is 1-855-669-9658 (USA) or 1-412-317-0088 (international), conference ID: 4178502.

A live webcast of the call will also be available from the Investor Relations section of the company’s website at investors.accuray.com. A webcast replay can be accessed on the website and will remain available until Accuray announces its results for the fourth quarter of fiscal 2026.

About Accuray
Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. We invent unique, market-changing solutions designed to deliver radiation treatments for even the most complex cases—while making commonly treatable cases even easier—to meet the full spectrum of patient needs. We are dedicated to continuous innovation in radiation therapy for oncology, neuro-radiosurgery, and beyond, as we partner with clinicians and administrators, empowering them to help patients get back to their lives, faster. Accuray is headquartered in Madison, Wisconsin, with facilities worldwide. To learn more, visit www.accuray.com or follow us on Facebook, LinkedIn, X, and YouTube.

Investor and Media Contact
Steve Monroe
VP, Financial Planning & Analysis, Accuray
Investor.relations@accuray.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/accuray-to-report-third-quarter-fiscal-2026-financial-results-on-may-6-2026-302750641.html

SOURCE Accuray Incorporated